CRF Sets New Industry Experience Record and Connects 85,000 Patients Across 55 Countries.

WALTHAM, Mass. and HELSINKI, Finland -- - Company raises benchmark in electronic patient diary experience for second time this year

- Clients report 95% compliance rates, reduced costs and accelerated access to trial data

CRF Inc., a leading provider of electronic diaries for capturing electronic Patient Reported Outcomes (ePRO) data in clinical trials, today announced that its electronic patient diaries (EPDs) have been used by more than 85,000 patients across 55 countries in 42 languages. This new data, collected in partnership with its customers, clinical trial sites, patients and regulatory agencies, reveals CRF has the most widely used EPD technology in the life sciences industry.

"We created this electronic diary nearly five years ago and have continuously worked with our clients, partners and industry experts to upgrade its technology and delivery," said Timo Ahopelto, Vice President of Operations and Co-founder of CRF. "Our EPD solution is the most widely used in the industry today because no other company can rival CRF's experience or technological expertise."

The average clinical study that CRF supports requires the deployment of both landline and wireless data transmission technology. Typical studies also involve more than 1,000 patients in 3 countries reporting efficacy, quality of life and safety data in 5 different languages. This data has been submitted to regulatory authorities both in the U.S. and EU.

"These new statistics are very exciting," said Pam McNamara, CEO of CRF. "We are currently reaching more patients in more therapeutic areas across more countries in more languages than any other electronic patient diary provider in the world. Moreover, the feedback we have received from our clients demonstrates CRF's technology is helping drug developers reduce costs and collect better data faster."

Customer response indicates CRF's technology has assisted biopharmaceutical companies collect more accurate patient data more efficiently. Compliance rates, which are defined by how much actual data is captured from the patient according to the protocol, for ePRO captured with CRF technology average 95 percent across major studies. This level of compliance strengthens trial claims and regulatory compliance. CRF clients have also reported overall clinical development costs have been reduced by up to 30 percent.

"At CRF, our primary objective is to help our customers realize their clinical goals," says Tanya Hair, Clinical Operations Officer at CRF Inc. "To accomplish this, we work closely with trial managers, clinical investigators and patients, using our knowledge of e-Diaries and clinical expertise in areas such as urology, gynecology, dermatology and oncology to develop and support clinical programs that work seamlessly."

About CRF Inc.

CRF Inc. provides electronic patient diaries (EPDs) and wireless data collection solutions to pharmaceutical and biotechnology companies, and contract research organizations around the world. More than 85,000 patients in 55 countries have used CRF's technology. Through a thorough understanding of drug development, mobile computing and academic research, the company assists its clients enhance their clinical trials, save resources, and increase the accuracy and reliability of collected clinical data. CRF's data collection solutions are compliant with U.S. and international standards for data quality and integrity. For more information, please visit www.crfhealth.com.